Рамиприл Тева 5 мг

국가: 이스라엘

언어: 러시아어

출처: Ministry of Health

지금 구매하세요

유효 성분:

RAMIPRIL 5 MG

제공처:

TEVA PHARMACEUTICAL INDUST.LTD

ATC 코드:

C09AA05

약제 형태:

TABLETS

관리 경로:

PER OS

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD

치료 그룹:

RAMIPRIL

치료 징후:

- Hypertension - Congestive heart failure - Reduction of mortality in patients after MI with left ventricular dysfunction For reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI unstable angina or multivessel CABG or multivessel PTCA) stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg) high total cholesterol (>5.2 mmol/L) low HDL ( <0.9 mmol/L) current smoker known microalbuminuria clinical evidence of previous vascular disease. - Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

승인 날짜:

2010-05-01

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 영어 29-01-2019
환자 정보 전단 환자 정보 전단 아랍어 13-08-2019
환자 정보 전단 환자 정보 전단 히브리어 13-08-2019

이 제품과 관련된 검색 알림